Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Neurochemistry|August 25, 2010
GFR α-1 receptor expression in the aging nigrostriatal and mesoaccumbens pathwaysBrandon S Pruett, Michael F Salvatore
Molecular Neurobiology|January 17, 2013
Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicityBrandon S Pruett, Michael F Salvatore
Alcohol (Fayetteville, N.Y.)|December 1, 2006
An explanation for the paradoxical induction and suppression of an acute phase response by ethanolBrandon S Pruett, Stephen B Pruett
Plos One|January 14, 2012
Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathwaysMichael F Salvatore, Brandon S Pruett
Schizophrenia Research|September 22, 2020
Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studiesBrandon S Pruett, James H Meador-Woodruff
Frontiers in Psychiatry|September 17, 2025
Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practicesAmie R Throneberry, Bradley G Burk, Brandon S Pruett
Journal of Visualized Experiments : Jove|August 22, 2012
Comprehensive profiling of dopamine regulation in substantia nigra and ventral tegmental areaMichael F Salvatore, Brandon S Pruett, Charles Dempsey, et al.
Plos One|December 29, 2009
Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generationMichael F Salvatore, Brandon S Pruett, Sandy L Spann, et al.
Translational Psychiatry|February 2, 2023
Altered distribution and localization of organellar Na+/H+ exchangers in postmortem schizophrenia dorsolateral prefrontal cortexBrandon S Pruett, Anita L Pinner, Pitna Kim, et al.
Acta Psychiatrica Scandinavica|May 17, 2023
Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting systemBradley G Burk, Tilyn DiGiacomo, Shea Polancich, et al.
Pageof 2